VRDN (Viridian Therapeutics, Inc.) operates in the Health technology sector. It's currently trading at $20.35. Our composite momentum score rates it 57/110 based on price +5.0% (1d), rsi 67.0 — approaching overbought, roc9 +16.7% — sharp acceleration, macd 0.55 — strong bullish crossover, and analyst: strong buy. Up 4.9% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.